Astera Labs (NASDAQ:ALAB) Director Sells $270,997.44 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Bethany Mayer sold 686 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the transaction, the director owned 5,550 shares of the company’s stock, valued at approximately $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Stock Performance

Shares of ALAB traded down $6.26 during mid-day trading on Friday, hitting $391.74. The company’s stock had a trading volume of 6,467,937 shares, compared to its average volume of 5,698,053. The stock’s 50-day moving average is $284.80 and its two-hundred day moving average is $194.71. The firm has a market capitalization of $67.15 billion, a PE ratio of 264.69, a price-to-earnings-growth ratio of 4.59 and a beta of 3.95. Astera Labs, Inc. has a one year low of $85.85 and a one year high of $440.99.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors have recently added to or reduced their stakes in the stock. Atreides Management LP raised its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Amundi boosted its stake in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC acquired a new stake in Astera Labs in the 3rd quarter valued at $209,599,000. BNP Paribas Financial Markets grew its position in Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after acquiring an additional 960,899 shares during the period. Finally, Artisan Partners Limited Partnership bought a new stake in Astera Labs in the fourth quarter valued at $148,980,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ALAB has been the subject of several research reports. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Stifel Nicolaus upped their price target on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday. UBS Group started coverage on Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective for the company. JPMorgan Chase & Co. lifted their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Finally, Susquehanna boosted their price objective on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $254.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.